麻豆传媒

Black patients "presenting more often, and they're presenting at a later stage," researcher says

Test could fill a gap in CRC screening

Better outcomes in short bowel syndrome and intestinal failure with apraglutide vs placebo

Dual-acting IL-23 inhibitor tops placebo, ustekinumab in phase III trials

First-in-human study targets ghrelin production with mucosal ablation as obesity treatment

Female patients appeared to derive the greatest benefit, researchers say

Observational study suggests benefit compared with laparoscopic surgery

But survey shows they still want a doctor in charge

Clearly helpful in manufacturers' trials, but not so much in routine practice

Oral treatment alleviates symptoms better than placebo

Trial boosts case for label expansion

Outdone by gastroenterologists in finding adenomatous polyps

Small trials show big boost in insulin sensitivity, plus weight loss

Small but clear boost to overall survival